Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents
RSC Medicinal Chemistry · 2025 · 16 (10) · 4657-4675
DOI: 10.1039/d5md00205b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von David C Magri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, University of Malta Msida MSD 2080 Malta david.magri@um.edu.mt +(356) 2340 2276. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Università ta' Malta.
Abstract (Originalsprache)
Naphthalimide–organometallic hybrids are reviewed as intelligent agents for antineoplastic and luminescence sensing applications.
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, University of Malta Msida MSD 2080 Malta david.magri@um.edu.mt +(356) 2340 2276.
ORCID-Profile: David C Magri, Alex D Johnson
Förderung
- Università ta' Malta
Zitieren
APA
Magri, D. C., & Johnson, A. D. (2025). Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents. RSC Medicinal Chemistry, 16(10), 4657-4675. https://doi.org/10.1039/d5md00205b
Vancouver
Magri DC, Johnson AD. Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents. RSC Medicinal Chemistry. 2025;16(10):4657-4675. doi:10.1039/d5md00205b
BibTeX
@article{Magri2025,
author = {Magri, David C and Johnson, Alex D},
title = {Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {10},
pages = {4657--4675},
doi = {10.1039/d5md00205b}
}
EUVIMED